▼ -100.00% Downside Potential
This price target is based on 6 analysts offering 12 month price targets for Zur Rose Group in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $377.00.
The current consensus among 6 contributing investment analysts is to buy stock in Zur Rose Group.
Zur Rose Group AG operates an e-commerce pharmacy and a wholesale business for medical and pharmaceutical products under the Zur Rose and DocMorris brands in Germany, Switzerland, and rest of Europe. The company offers consumer health, beauty, and personal care products. It also provides medicines management services. The company sells its products directly to physicians, online mail-order pharmacies, and private individuals. In addition, it operates stationary pharmacy shops. The company was formerly known as Zur Rose AG and changed its name to Zur Rose Group AG in May 2015. Zur Rose Group AG was founded in 1993 and is headquartered in Frauenfeld, Switzerland.